Expedeon AG, formerly Sygnis AG, is a Germany-based biotechnology company. The Company develops and markets molecular-diagnostic technologies, such as in field of deoxyribonucleic acid (DNA) amplification and sequencing. The Company's solutions are used in drug discovery research and diagnostic product development and include TruePrime whole genome amplification technology, the Lightning-Link antibody labeling technology, the CaptSure single-step antibody capture technology, the RunBlue Bis Tris gels for electrophoresis, and colloidal gold nanoparticles for point of care lateral flow assays, such as pregnancy testing, among others. In addition, the Company offers custom services, such as antibody and particle conjugation, as well as delivers bulk orders. The Company operates through subsidiaries in Germany, Spain, the United Kingdom and the United States.